The results of GSEA based on the TMB data showed that the PCLO mutation may be associated with the activation of ‘Alzheimers disease’, ‘Huntingtons disease’, ‘oxidative phosphorylation’, ‘Parkinsons disease’, and the ‘proteasome’ pathway (Figure 4a). This evidence concerns the gene PCLO and Huntington disease.